Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019893 |
---|---|
Receipt number | R000022856 |
Scientific Title | Phase II study of biweekly cetuximab and irinotecan as third-line therapy in patients with pre-treated KRAS exon2 wild-type metastatic colorectal cancer |
Date of disclosure of the study information | 2015/11/24 |
Last modified on | 2015/11/14 15:30:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/11/22 13:16:41 |